Conjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells.
AffiliationCRC Institute for Cancer Studies, University of Birmingham, Birmingham, B15 2TA United Kingdom.
MetadataShow full item record
AbstractConjugation of folate to proteins permits receptor-mediated endocytosis via the folate receptor (FR) and delivery of the conjugate into the cytoplasm of cells. Since many cancers up-regulate the FR it has enabled the targeting of toxins to tumor cells resulting in specific cell death. However, current conjugation methods rely on chemistries that can affect certain catalytic subunits, such as the A-chain of the plant toxin gelonin. As a result many folate-targeted toxins are a compromise between receptor/ligand interaction and toxin activity. We describe the first example of folate conjugated to a protein via carbohydrate residues, using a novel SH-folate intermediate. The folate-gelonin conjugate retains over 99% of toxin activity in a cell-free translational assay compared with unmodified gelonin and is able to bind the FR at the same affinity as free folic acid (10(-10) m). Additionally, the conjugate exhibits prolonged inhibition of protein synthesis in FR positive cell lines in vitro. Folate linked to gelonin via amino conjugation exhibits the same affinity for FR as free folic acid but the toxin is 225-fold less active in a cell-free translational assay. The effect of different conjugation methods on toxin activity and the implications for folate targeting of other glycoproteins are discussed.
CitationConjugation of folate via gelonin carbohydrate residues retains ribosomal-inactivating properties of the toxin and permits targeting to folate receptor positive cells. 2001, 276 (30):27930-5 J. Biol. Chem.
JournalThe Journal of Biological Chemistry
- Hormonotoxins: abrogation of ribosome inactivating property of gelonin in the disulfide linked ovine luteinizing hormone-gelonin conjugates.
- Authors: Singh V, Curtiss R 3rd
- Issue date: 1991 Oct
- Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery.
- Authors: Paulos CM, Reddy JA, Leamon CP, Turk MJ, Low PS
- Issue date: 2004 Dec
- Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
- Authors: Leamon CP, Cooper SR, Hardee GE
- Issue date: 2003 Jul-Aug
- Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
- Authors: Leamon CP, Reddy JA, Vetzel M, Dorton R, Westrick E, Parker N, Wang Y, Vlahov I
- Issue date: 2008 Dec 1
- [Anticancer activity of N-(phenylacetyl) doxorubicin combined with folate-targeted PGA].
- Authors: Zhang Q, Xiang GY, Long N, Lin JL, Zeng FB
- Issue date: 2005 Nov